{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:08:39Z","timestamp":1761764919262,"version":"3.33.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s11920-004-0012-1","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T05:06:58Z","timestamp":1181365618000},"page":"466-472","source":"Crossref","is-referenced-by-count":17,"title":["Neurochemical predictors of response to pharmacologic treatments for bipolar disorder"],"prefix":"10.1007","volume":"6","author":[{"given":"Melissa P.","family":"DelBello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Strakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0165-0327(94)90104-X","volume":"31","author":"JD Lish","year":"1994","unstructured":"Lish JD, Dime-Meenan S, Whybrow PC, et al.: The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994, 31:281\u2013294.","journal-title":"J Affect Disord"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","volume":"51","author":"RC Kessler","year":"1994","unstructured":"Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8\u201319.","journal-title":"Arch Gen Psychiatry"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1034\/j.1399-5618.2000.20309.x","volume":"2","author":"PM Lewinsohn","year":"2000","unstructured":"Lewinsohn PM, Klein DN, Seeley JR: Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord 2000, 2:281\u2013293.","journal-title":"Bipolar Disord"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4088\/JCP.v61n0104","volume":"61","author":"MA Frye","year":"2000","unstructured":"Frye MA, Ketter TA, Leverich GS, et al.: The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000, 61:9\u201315.","journal-title":"J Clin Psychiatry"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/104454603322724904","volume":"13","author":"RK Bhangoo","year":"2003","unstructured":"Bhangoo RK, Lowe CH, Myers FS, et al.: Medication use in children and adolescents treated in the community for bipolar disorder. J Child Adolesc Psychopharmacol 2003, 13:515\u2013522.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1023\/B:ACLI.0000008174.46414.a4","volume":"15","author":"AJ Gelenberg","year":"2003","unstructured":"Gelenberg AJ, Pies R: Matching the bipolar patient and the mood stabilizer. Ann Clin Psychiatry 2003, 15:203\u2013216.","journal-title":"Ann Clin Psychiatry"},{"key":"12_CR7","first-page":"25","volume":"56","author":"CL Bowden","year":"1995","unstructured":"Bowden CL: Predictors of response to divalproex and lithium. J Clin Psychiatry 1995, 56:25\u201330.","journal-title":"J Clin Psychiatry"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/(SICI)1522-7162(1996)4:1<14::AID-DEPR2>3.0.CO;2-F","volume":"4","author":"JC Soares","year":"1996","unstructured":"Soares JC, Krishnan KR, Keshavan MS: Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression 1996, 4:14\u201330.","journal-title":"Depression"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1176\/jnp.10.2.133","volume":"10","author":"T Kato","year":"1998","unstructured":"Kato T, Inubushi T, Kato N: Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci 1998, 10:133\u2013147.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1023\/A:1024684225114","volume":"15","author":"RM Post","year":"2003","unstructured":"Post RM, Speer AM, Hough CJ, et al.: Neurobiology of bipolar illness: implications for future study and therapeutics. Ann Clin Psychiatry 2003, 15:85\u201394.","journal-title":"Ann Clin Psychiatry"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1034\/j.1399-5618.2000.020302.x","volume":"2","author":"SM Strakowski","year":"2000","unstructured":"Strakowski SM, DelBello MP, Adler C, et al.: Neuroimaging in bipolar disorder. Bipolar Disord 2000, 2:148\u2013164. This literature review provided a thorough overview of recent neuroimaging studies in patients with bipolar disorder.","journal-title":"Bipolar Disord"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1053\/scnp.2002.35226","volume":"7","author":"D Glitz","year":"2002","unstructured":"Glitz D, Manji H, Moore GJ: Mood disorders: Treatmentinduced changes in brain neurochemistry and structure. Semin Clin Neuropsychiatry 2002, 7:269\u2013280.","journal-title":"Semin Clin Neuropsychiatry"},{"key":"12_CR13","first-page":"5","volume":"36","author":"GJ Moore","year":"2002","unstructured":"Moore GJ, Galloway MP: Magnetic resonance spectroscopy: Neurochemistry and treatment effects in affective disorders. Psychopharm Bull 2002, 36:5\u201323.","journal-title":"Psychopharm Bull"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0924-977X(00)00057-2","volume":"10","author":"JC Soares","year":"2000","unstructured":"Soares JC, Boada F, Matcheri S, et al.: Brain lithium measurements with (7)Li magnetic resonance spectroscopy (MRS): a literature review. Eur Neuropsychopharmacol 2000, 10:151\u2013158. This literature review provides a comprehensive discussion of the methodologic limitations and utility of 7Li MRS.","journal-title":"Eur Neuropsychopharmacol"},{"key":"12_CR15","unstructured":"Strakowski SM, DelBello MP, Adler CM: The functional neuroanatomy of bipolar disorder. Mol Psychiatry. In press."},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1034\/j.1399-5618.2002.01160.x","volume":"4","author":"SM Strakowski","year":"2002","unstructured":"Strakowski SM, Adler CM, DelBello MP: Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? Bipolar Disord 2002, 4:80\u201388.","journal-title":"Bipolar Disord"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0301-0082(95)00014-M","volume":"46","author":"G Tsai","year":"1995","unstructured":"Tsai G, Coyle JT: N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995, 46:531\u2013540.","journal-title":"Prog Neurobiol"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0006-3223(99)00183-3","volume":"15","author":"ME Winsberg","year":"2000","unstructured":"Winsberg ME, Sachs N, Tate DL, et al.: Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000, 15:475\u2013481.","journal-title":"Biol Psychiatry"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1034\/j.1399-5618.2002.02235.x","volume":"4","author":"KM Cecil","year":"2002","unstructured":"Cecil KM, DelBello MP, Morey R, et al.: Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 2002, 4:357\u2013365.","journal-title":"Bipolar Disord"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0006-3223(02)01911-X","volume":"15","author":"A Bertolino","year":"2003","unstructured":"Bertolino A, Frye M, Callicott JH, et al.: Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003, 15:906\u2013913.","journal-title":"Biol Psychiatry"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1176\/appi.ajp.160.5.873","volume":"160","author":"RF Deicken","year":"2003","unstructured":"Deicken RF, Pegues MP, Anzalone S, et al.: Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 2003, 160:873\u2013882.","journal-title":"Am J Psychiatry"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0925-4927(98)00050-X","volume":"84","author":"K Ohara","year":"1998","unstructured":"Ohara K, Isoda H, Suzuki Y, et al.: Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Res 1998, 84:55\u201360.","journal-title":"Psychiatry Res"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0925-4927(00)00083-4","volume":"106","author":"RF Deicken","year":"2001","unstructured":"Deicken RF, Eliaz Y, Feiwell R, et al.: Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Res 2001, 106:35\u201345.","journal-title":"Psychiatry Res"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0006-3223(02)01744-4","volume":"53","author":"K Chang","year":"2003","unstructured":"Chang K, Adleman N, Dienes K, et al.: Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry 2003, 53:1059\u20131065.","journal-title":"Biol Psychiatry"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/104454603322724931","volume":"13","author":"KM Cecil","year":"2003","unstructured":"Cecil KM, DelBello MP, Sellars MC, et al.: Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. J Child Adolesc Psychopharmacol 2003, 13:545\u2013555.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0920-9964(92)90059-E","volume":"8","author":"R Sharma","year":"1992","unstructured":"Sharma R, Venkatasubramanian PN, Barany M, et al.: Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr Res 1992, 8:43\u201349.","journal-title":"Schizophr Res"},{"key":"12_CR27","first-page":"248","volume":"21","author":"T Kato","year":"1996","unstructured":"Kato T, Hamakawa H, Shioiri T, et al.: Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 1996, 21:248\u2013254.","journal-title":"J Psychiatry Neurosci"},{"key":"12_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0893-133X(00)00207-4","volume":"24","author":"P Davanzo","year":"2001","unstructured":"Davanzo P, Thomas MA, Yue K, et al.: Decreased anterior cingulated myo-inositol\/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001, 24:359\u2013369.","journal-title":"Neuropsychopharmacology"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-3223(00)00252-3","volume":"48","author":"GJ Moore","year":"2000","unstructured":"Moore GJ, Bebchuk JM, Hasanat K, et al.: Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2\u2032s neurotrophic effects? Biol Psychiatry 2000, 48:1\u20138. This is a methodologically rigorous 1H MRS study that longitudinally assessed the effects of lithium in depressed bipolar patients. This study design should be used to guide the development of future 1H MRS studies.","journal-title":"Biol Psychiatry"},{"key":"12_CR30","doi-asserted-by":"crossref","unstructured":"Brambilla P, Stanley JA, Sassi RB, et al.: 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004, epub ahead of print on PubMed.","DOI":"10.1038\/sj.npp.1300520"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00004850-200303000-00002","volume":"18","author":"PH Silverstone","year":"2003","unstructured":"Silverstone PH, Wu RH, O\u2019Donnell T, et al.: Chronic treatment with lithium, but not sodium valproate, increases cortical Nacetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 2003, 18:73\u201379.","journal-title":"Int Clin Psychopharmacol"},{"key":"12_CR32","unstructured":"DelBello MP, Kowatch RA, Cecil KM, et al.: The neuropathophysiology of adolescent bipolar disorder. Presented at American Academy of Child and Adolescent Psychiatry Annual Meeting. Miami, FL, October, 2003."},{"key":"12_CR33","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1016\/S0021-9258(19)70391-3","volume":"255","author":"LM Hallcher","year":"1980","unstructured":"Hallcher LM, Sherman WR: The effect of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Bio Chem 1980, 255:10896\u201310901.","journal-title":"J Bio Chem"},{"key":"12_CR34","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1176\/ajp.156.12.1902","volume":"156","author":"GJ Moore","year":"1999","unstructured":"Moore GJ, Bebchuk JM, Parrish JK, et al.: Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 1999, 156:1902\u20131908.","journal-title":"Am J Psychiatry"},{"key":"12_CR35","unstructured":"Bruhn H, Stoppe G, Staedt J, et al.: Quantitative proton MRS in vivo shows cerebral myo-inositol and choline to be unchanged in manic-depressive patients treated with lithium. Proc Soc Magnetic Resonance Med 1993, (abstract) 1543."},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/hup.420","volume":"17","author":"PH Silverstone","year":"2002","unstructured":"Silverstone PH, Wu RH, O\u2019Donnell T, et al.: Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Hum Psychopharmacol 2002, 17:321\u2013327.","journal-title":"Hum Psychopharmacol"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1034\/j.1399-5618.2000.20302.x","volume":"2","author":"CM Moore","year":"2000","unstructured":"Moore CM, Breeze JL, Gruber SA, et al.: Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulated cortex. Bipolar Disord 2000, 2:207\u2013216.","journal-title":"Bipolar Disord"},{"key":"12_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0006-3223(95)00382-7","volume":"15","author":"PH Silverstone","year":"1996","unstructured":"Silverstone PH, Hanstock CC, Fabian J, et al.: Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS. Biol Psychiatry 1996, 15:235\u2013246.","journal-title":"Biol Psychiatry"},{"key":"12_CR39","doi-asserted-by":"crossref","unstructured":"Wu RH, O\u2019Donnell T, Ulrich M, et al.: Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate. Ann Gen Hosp Psychiatry 2004, 3: Epub ahead of print.","DOI":"10.1186\/1475-2832-3-13"},{"key":"12_CR40","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/0006-3223(92)90184-2","volume":"32","author":"AL Stoll","year":"1992","unstructured":"Stoll AL, Renshaw PF, Sachs GS, et al.: The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 1992, 32:944\u2013949.","journal-title":"Biol Psychiatry"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"68S","DOI":"10.1016\/0006-3223(94)90910-5","volume":"35","author":"B Lafer","year":"1994","unstructured":"Lafer B, Renshaw PF, Sachs G, et al.: Proton MRS of the basal ganglia in bipolar patients. Biol Psychiatry 1994, 35(abstract):68S.","journal-title":"Biol Psychiatry"},{"key":"12_CR42","first-page":"222","volume":"24","author":"PH Silverstone","year":"1999","unstructured":"Silverstone PH, Hanstock CC, Rotzinger S: Lithium does not alter the choline\/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy. J Psychiatry Neurosci 1999, 24:222\u2013226.","journal-title":"J Psychiatry Neurosci"},{"key":"12_CR43","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0006-3223(95)00423-8","volume":"40","author":"AL Stoll","year":"1996","unstructured":"Stoll AL, Sachs GS, Cohen BM, et al.: Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium treated patients. Biol Psychiatry 1996, 40:382\u2013388.","journal-title":"Biol Psychiatry"},{"key":"12_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1034\/j.1399-5618.2003.00041.x","volume":"5","author":"IK Lyoo","year":"2003","unstructured":"Lyoo IK, Demopulos CM, Hirashima F, et al.: Oral choline decreases brain purine levels in lithium-treated subjects with rapid cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy. Bipolar Disord 2003, 5:300\u2013306.","journal-title":"Bipolar Disord"},{"key":"12_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00213-003-1440-z","volume":"168","author":"N Michael","year":"2003","unstructured":"Michael N, Erfurth A, Ohrmann P, et al.: Acute mania is accompanied by elevated glutamate\/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology 2003, 168:344\u2013346.","journal-title":"Psychopharmacology"},{"key":"12_CR46","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","volume":"61","author":"SR Dager","year":"2004","unstructured":"Dager SR, Friedman SD, Parow A, et al.: Brian metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004, 61:450\u2013458.","journal-title":"Arch Gen Psychiatry"},{"key":"12_CR47","first-page":"832","volume":"21","author":"M Castillo","year":"2000","unstructured":"Castillo M, Kwock L, Courvoisie H, et al.: Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. Am J Neuroradiol 2000, 21:832\u2013838.","journal-title":"Am J Neuroradiol"},{"key":"12_CR48","first-page":"287","volume":"3","author":"NE Preece","year":"1992","unstructured":"Preece NE, Gadian DG, Houseman J, et al.: Lithium-induced modulation of cerebral inositol phosphate metabolism in the rat: a multinuclear magnetic resonance study in vivo. Lithium 1992, 3:287\u2013297.","journal-title":"Lithium"},{"key":"12_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1017\/S1461145799001674","volume":"3","author":"T Kato","year":"2000","unstructured":"Kato T, Inubushi T, Kato N: Prediction of lithium response by 31P-MRS in bipolar disorder. Int J Neuropsychoparmacol 2000, 3:83\u201385.","journal-title":"Int J Neuropsychoparmacol"},{"key":"12_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mrm.1910040303","volume":"4","author":"PF Renshaw","year":"1987","unstructured":"Renshaw PF, Schnall MD, Leigh Jr JS: In vivo 31P NMR spectroscopy of agonist-stimulated phosphatidylinositol metabolism in cat brain. Magn Reson Med 1987, 4:221\u2013226.","journal-title":"Magn Reson Med"},{"key":"12_CR51","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/mrm.1910150302","volume":"15","author":"RA Komoroski","year":"1990","unstructured":"Komoroski RA, Newton JE, Walker E, et al.: In vivo NMR spectroscopy of lithium-7 in humans. Magn Reson Med 1990, 15:347\u2013356.","journal-title":"Magn Reson Med"},{"key":"12_CR52","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/0006-3223(91)90324-F","volume":"15","author":"L Gyulai","year":"1991","unstructured":"Gyulai L, Wicklund SW, Greenstein R, et al.: Measurement of tissue lithium concentration by lithium magnetic resonance spectroscopy in patients with bipolar disorder. Biol Psychiatry 1991, 15:1161\u20131170.","journal-title":"Biol Psychiatry"},{"key":"12_CR53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0925-4927(92)90013-T","volume":"45","author":"T Kato","year":"1992","unstructured":"Kato T, Takahashi S, Inubushi T: Brain lithium concentration by 7Li- and 1H-magnetic resonance spectroscopy in bipolar disorder. Psychiatry Res 1992, 45:53\u201363.","journal-title":"Psychiatry Res"},{"key":"12_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0006-3223(93)90133-X","volume":"33","author":"T Kato","year":"1993","unstructured":"Kato T, Shioiri T, Inubushi T, et al.: Brain lithium concentrations measured with lithium-7 magnetic resonance spectroscopy in patients with affective disorders: relationship to erythrocyte and serum concentrations. Biol Psychiatry 1993, 33:147\u2013152.","journal-title":"Biol Psychiatry"},{"key":"12_CR55","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/00004714-199410000-00007","volume":"14","author":"T Kato","year":"1994","unstructured":"Kato T, Inubushi T, Takahashi S: Relationship of lithium concentrations in the brain measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania. J Clin Psychopharmacol 1994, 14:330\u2013335.","journal-title":"J Clin Psychopharmacol"},{"key":"12_CR56","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/0006-3223(94)00324-V","volume":"38","author":"GS Sachs","year":"1995","unstructured":"Sachs GS, Renshaw PF, Lafer B, et al.: Gonzalez RG: Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study. Biol Psychiatry 1995, 38:422\u2013428.","journal-title":"Biol Psychiatry"},{"key":"12_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF02246668","volume":"124","author":"HV Jensen","year":"1996","unstructured":"Jensen HV, Plenge P, Stensgaard A, et al.: Twelve-hour brain lithium concentration in lithium maintenance treatment of manic-depressive disorder: daily versus alternate-day dosing schedule. Psychopharmacology 1996, 124:275\u2013278.","journal-title":"Psychopharmacology"},{"key":"12_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0278-5846(95)00294-4","volume":"20","author":"T Kato","year":"1996","unstructured":"Kato T, Fujii K, Shioiri T, et al.: Lithium side effects in relation to brain lithium concentration measured by lithium-7 magnetic resonance spectroscopy. Pro Neuropsychopharmacol Biol Psychiatry 1996, 20:87\u201397.","journal-title":"Pro Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0012-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-004-0012-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0012-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0012-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T04:26:47Z","timestamp":1737088007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-004-0012-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s11920-004-0012-1","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"type":"print","value":"1523-3812"},{"type":"electronic","value":"1535-1645"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}